These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 19888879

  • 1. Respiratory delivery of theophylline by size-targeted starch microspheres for treatment of asthma.
    Momeni A, Mohammadi MH.
    J Microencapsul; 2009 Dec; 26(8):701-10. PubMed ID: 19888879
    [Abstract] [Full Text] [Related]

  • 2. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R, Sultana Y, Aqil M, Ali A, Kumar S, Chuttani K, Mishra AK.
    Int J Pharm; 2007 Apr 04; 334(1-2):71-7. PubMed ID: 17113732
    [Abstract] [Full Text] [Related]

  • 3. Preparation and characterization of glutaraldehyde cross-linked O-carboxymethylchitosan microspheres for controlled delivery of pazufloxacin mesilate.
    Liu YF, Huang KL, Peng DM, Ding P, Li GY.
    Int J Biol Macromol; 2007 Jun 01; 41(1):87-93. PubMed ID: 17292465
    [Abstract] [Full Text] [Related]

  • 4. Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for pylorospasm.
    Sultana S, Bhavna, Iqbal Z, Panda BP, Talegaonkar S, Bhatnagar A, Ahmad FJ.
    J Microencapsul; 2009 Aug 01; 26(5):385-93. PubMed ID: 18720200
    [Abstract] [Full Text] [Related]

  • 5. Preparation of gelatin microspheres containing lactic acid--effect of cross-linking on drug release.
    Dinarvand R, Mahmoodi S, Farboud E, Salehi M, Atyabi F.
    Acta Pharm; 2005 Mar 01; 55(1):57-67. PubMed ID: 15907224
    [Abstract] [Full Text] [Related]

  • 6. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology.
    Emami J, Hamishehkar H, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Mirzadeh H, Fakhari A, Nokhodchi A.
    J Microencapsul; 2009 Feb 01; 26(1):1-8. PubMed ID: 18465287
    [Abstract] [Full Text] [Related]

  • 7. Viscosity of polymer solution phase and other factors controlling the dissolution of theophylline microspheres prepared by the emulsion solvent evaporation method.
    Obeidat WM, Price JC.
    J Microencapsul; 2003 Feb 01; 20(1):57-65. PubMed ID: 12519702
    [Abstract] [Full Text] [Related]

  • 8. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.
    Mathew ST, Devi SG, KV S.
    AAPS PharmSciTech; 2007 Feb 23; 8(1):14. PubMed ID: 17408214
    [Abstract] [Full Text] [Related]

  • 9. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.
    Eur J Pharm Biopharm; 2008 Sep 23; 70(1):302-12. PubMed ID: 18579353
    [Abstract] [Full Text] [Related]

  • 10. Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres.
    Gayakwad SG, Bejugam NK, Akhavein N, Uddin NA, Oettinger CE, D'Souza MJ.
    J Microencapsul; 2009 Dec 23; 26(8):692-700. PubMed ID: 19888878
    [Abstract] [Full Text] [Related]

  • 11. Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman.
    Gupta KC, Jabrail FH.
    Carbohydr Res; 2006 May 01; 341(6):744-56. PubMed ID: 16499893
    [Abstract] [Full Text] [Related]

  • 12. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
    Shaheen SM, Takezoe K, Yamaura K.
    Biomed Mater Eng; 2004 May 01; 14(4):371-82. PubMed ID: 15472386
    [Abstract] [Full Text] [Related]

  • 13. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
    Mastiholimath VS, Dandagi PM, Jain SS, Gadad AP, Kulkarni AR.
    Int J Pharm; 2007 Jan 02; 328(1):49-56. PubMed ID: 16942847
    [Abstract] [Full Text] [Related]

  • 14. Intranasal administration of melatonin starch microspheres.
    Mao S, Chen J, Wei Z, Liu H, Bi D.
    Int J Pharm; 2004 Mar 19; 272(1-2):37-43. PubMed ID: 15019067
    [Abstract] [Full Text] [Related]

  • 15. [Preparation of uniform-sized chitosan microspheres and application as carriers for protein drugs].
    Gu YH, Wang LY, Tan TW, Ma GH.
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan 19; 22(1):150-5. PubMed ID: 16572856
    [Abstract] [Full Text] [Related]

  • 16. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin.
    Anal AK, Stevens WF, Remuñán-López C.
    Int J Pharm; 2006 Apr 07; 312(1-2):166-73. PubMed ID: 16497452
    [Abstract] [Full Text] [Related]

  • 17. Preparation and characterization of uniform-sized chitosan microspheres containing insulin by membrane emulsification and a two-step solidification process.
    Wang LY, Gu YH, Zhou QZ, Ma GH, Wan YH, Su ZG.
    Colloids Surf B Biointerfaces; 2006 Jul 01; 50(2):126-35. PubMed ID: 16787743
    [Abstract] [Full Text] [Related]

  • 18. Novel sustained release microspheres for pulmonary drug delivery.
    Cook RO, Pannu RK, Kellaway IW.
    J Control Release; 2005 May 05; 104(1):79-90. PubMed ID: 15866336
    [Abstract] [Full Text] [Related]

  • 19. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
    Wang LY, Gu YH, Su ZG, Ma GH.
    Int J Pharm; 2006 Mar 27; 311(1-2):187-95. PubMed ID: 16436319
    [Abstract] [Full Text] [Related]

  • 20. [Efficiency and safety of anhydrous theophylline in delayed-release microspheres in the treatment of bronchial asthma].
    Huerta JG, Moguel A.
    Rev Alerg Mex (1987); 1988 Mar 27; 35(2):41-6. PubMed ID: 3389490
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.